 Tiziana Life Sciences Ltd NASDAQ:TLSA has presented posters on intranasal foralumab at the Preserving the Brain scientific conference, a scientific forum and exhibit on neurodegenerative diseases as part of human brains held at the Fondazione Prada in Milan, Italy. Further, the company said the first secondary progressive multiple sclerosis patient receiving intranasal foralumab was interviewed by Tiziana scientific advisory board chairman Howard Weiner. 